“Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S37. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/764.